Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy

Figure 3

The rates of improvement, maintenance, and deterioration of eGFR in all patients and in patients at high risk for renal toxicity, including hepatic decompensation (), DM (), CKD-3 (), concomitant usage of adefovir (), and contrast medium exposure (). The rates of improvement of eGFR in patients with DM and CKD-3 were significantly higher than the rate for all the patients (both ).